Skip to content
Sunday, March 7, 2021
Latest:
  • Common myths and truths about lymphedema
  • Pandemic, power outages, and…policy on child poverty?
  • Proteomics analysis identifies potential drug targets for aggressive human cancers
  • Resonance podcast: Clinical education and the art of ballroom dancing
  • Image of the Month: The laboratory worm, C. elegans

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Connect With Us
  • bcm.edu

MAPK4

From The Labs 

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021 Ana Rodríguez 0 Comments Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs features an image of the laboratory worm, Caenorhabditis elegans. Image credit: Dr. Tao Chen/Wang lab.

Healthy Habits: A DOC-umentary Series

https://youtu.be/MAXO08xs9fc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951